Covilife Ivermectin 40 mg

What Is Covilife Ivermectin 40 mg?

Covilife Ivermectin 40 mg is a high-strength prescription oral antiparasitic tablet used to treat specific parasitic infections caused by susceptible worms and parasites. It belongs to the avermectin antiparasitic drug class and works by targeting the nervous and muscular systems of susceptible parasites, causing their paralysis and allowing the body to eliminate them naturally.

The 40mg strength is a higher-dose formulation intended for patients whose body weight or clinical condition requires a higher dose as specifically determined by a prescribing healthcare professional. This strength must not be used without a valid prescription and thorough medical evaluation.

Manufacturer Details

Covilife Ivermectin 40 mg Tablets are manufactured by Kachhela Medex Pvt. Ltd., a licensed pharmaceutical manufacturer producing antiparasitic and other medicines in compliance with applicable Good Manufacturing Practice (GMP) standards. Manufacturing is carried out in certified pharmaceutical facilities under stringent quality control procedures to ensure consistent product quality, purity, and potency in every tablet produced.

Each tablet contains Ivermectin 40 mg as the active ingredient in oral tablet form. The product carries prescription-only medicine status and is packaged in strips of 10 tablets per strip for convenient storage and dispensing.

How Does Covilife Ivermectin 40 mg Work?

• After oral intake, Ivermectin is absorbed and reaches parasitic organisms present within the body through the bloodstream
• It binds selectively to glutamate-gated chloride ion channels in the nerve and muscle cells of susceptible invertebrate parasites
• This binding increases cell membrane permeability to chloride ions
• The result is hyperpolarization of parasitic nerve and muscle cells — causing complete and sustained paralysis of the parasite
• Once paralyzed, the parasite cannot feed, reproduce, or maintain its position within the host body
• The body's natural immune and digestive processes then eliminate the paralyzed parasites

These specific glutamate-gated chloride channels are not present in mammals, which is why Ivermectin selectively targets parasites rather than host cells in clinical use.

Commonly Prescribed Uses

Healthcare providers prescribe Covilife Ivermectin 40mg Tablets for:

• Strongyloidiasis — intestinal infection caused by Strongyloides stercoralis affecting the gastrointestinal tract
• Onchocerciasis (river blindness) — parasitic infection caused by Onchocerca volvulus affecting skin and eyes
• Scabies — skin infestation caused by Sarcoptes scabiei mites in appropriate clinical situations
• Other parasitic infestations — as determined through clinical evaluation and laboratory findings

All prescribing decisions are made entirely by a qualified healthcare professional based on body weight assessment, clinical examination, laboratory results where applicable, and individual patient health factors.

Benefits

• High-strength 40mg formulation — suitable for patients requiring higher weight-based doses as prescribed
• Established antiparasitic activity against a broad range of susceptible parasitic organisms
• Targets parasite nervous and muscular systems directly — causing paralysis and natural elimination
• Single-dose or short-course treatment for many indicated infections
• Well-documented global clinical use spanning decades of antiparasitic practice
• Manufactured by Kachhela Medex Pvt. Ltd. in GMP-certified facilities for consistent quality
• 10 tablets per strip packaging for convenient storage and handling
• Available through MayoPills with discreet packaging and tracked delivery in 7 to 10 business days

How to Take

• Take Covilife Ivermectin 40mg exactly as prescribed by your healthcare provider
• Swallow the tablet whole with a full glass of water
• Do not crush, chew, or break the tablet before swallowing
• Take on an empty stomach — at least 1 hour before a meal — unless your healthcare provider specifically instructs otherwise
• Take doses at the exact timing and intervals specified by your prescribing physician
• Complete the entire prescribed course without stopping early
• Never share this medicine with another person regardless of similar symptoms

Dosage Information

The appropriate dose depends on several individual clinical factors:

• Type of parasitic infection being treated
• Patient body weight — Ivermectin dosing is weight-based in most clinical situations
• Severity of the infection and parasite burden
• Immune status — immunocompromised patients may require additional doses
• Kidney and liver function
• Other medicines currently being taken

Only a qualified healthcare professional can determine the correct dose and treatment duration.

The 40mg strength is a high-strength formulation and should only be prescribed when clearly clinically indicated based on individual weight-based dosing requirements. Never adjust the dose independently without direct medical advice.

How Long Should Treatment Continue?

Treatment duration with Covilife Ivermectin 40 mg depends entirely on the type of parasitic infection and the individual patient's clinical response to therapy.

Some infections may be effectively addressed with a single prescribed dose, while others may require repeat doses at scheduled intervals as directed by the treating physician. Patients with chronic infections or compromised immune systems may require longer or repeated treatment courses under close clinical monitoring.

Do not stop, restart, or extend the treatment period without consulting your healthcare provider. Follow-up stool tests or clinical review may be required to confirm the infection has been fully resolved.

Possible Side Effects

Not all patients experience side effects. Most reported effects are mild and temporary.

Commonly reported side effects include:

• Headache
• Dizziness
• Nausea
• Stomach discomfort or abdominal pain
• Diarrhea
• Skin itching or rash
• Fatigue or mild weakness

Less commonly reported:

• Swelling of the face or limbs
• Fever
• Temporary changes in heart rate
• Mazzotti reaction — temporary worsening of skin or eye symptoms in onchocerciasis patients related to the immune response to dying parasites

Seek immediate medical attention if you experience:

• Severe allergic reaction — swelling of the face, lips, or throat, difficulty breathing, or widespread hives
• Neurological symptoms — confusion, difficulty walking, seizures, or loss of consciousness
• Severe skin reactions — widespread blistering, peeling, or raw skin areas
• Overdose symptoms — severe dizziness, confusion, very low blood pressure, or loss of consciousness after exceeding the prescribed dose should be treated as a medical emergency

Contraindications

Do not use Covilife Ivermectin 40 mg without medical guidance if you have:

• Known hypersensitivity or allergy to Ivermectin or any tablet ingredient
• History of severe reactions to antiparasitic medicines
• Medical conditions requiring special monitoring as determined by your healthcare provider

Warnings & Precautions

• Pregnancy — use only when clearly necessary and directly prescribed by a healthcare professional
• Breastfeeding — consult your healthcare provider before taking this medicine
• Liver disease — patients with liver impairment should use this medicine with caution and under close clinical monitoring
• Children — safety and appropriate dosage must be determined entirely by a qualified pediatric healthcare provider
• Elderly patients — dose adjustments and closer monitoring may be required based on individual health status
• Heart conditions and nervous system disorders — inform your healthcare provider before starting treatment
• Alcohol — avoid during treatment as it may increase the risk of adverse effects

Always follow the complete instructions provided by your healthcare professional throughout the entire treatment period.

Drug Interactions

• Warfarin and anticoagulants — Ivermectin may enhance anticoagulant effects and increase bleeding risk; monitoring may be required
• CNS depressants — medicines affecting the central nervous system may produce enhanced effects when combined with Ivermectin
• Barbiturates and anticonvulsants — may interact with Ivermectin metabolism and activity
• Valproic acid — potential interaction affecting nervous system function
• Other antiparasitic medicines — combined use requires careful clinical assessment
• Alcohol — concurrent use may intensify adverse effects

Always inform your healthcare provider and pharmacist about every prescription medicine, over-the-counter product, vitamin, and herbal supplement currently being taken before starting Covilife Ivermectin 40 mg.

Storage

• Store at room temperature below 25°C or 77°F
• Keep away from direct sunlight, heat, and moisture
• Store in original strip packaging until ready for use
• Keep out of reach of children and pets at all times
• Do not use past the printed expiry date
• Dispose of unused or expired tablets following local pharmaceutical waste disposal regulations